Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017 (Unknown)
Free access
- New search for: Durup, Darshana
- New search for: Schaffalitzky de Muckadell, Philip
- New search for: Strom, Claes Christian
- New search for: Durup, Darshana
- New search for: Schaffalitzky de Muckadell, Philip
- New search for: Strom, Claes Christian
In:
Expert Review of Hematology
;
13
, 5
;
557-564
;
2020
- Article (Journal) / Electronic Resource
-
Title:Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017
-
Contributors:Durup, Darshana ( author ) / Schaffalitzky de Muckadell, Philip ( author ) / Strom, Claes Christian ( author )
-
Published in:Expert Review of Hematology ; 13, 5 ; 557-564
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2020-05-03
-
Size:8 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 13, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 435
-
A critical evaluation of pembrolizumab in addition to lenalidomide and dexamethasone for the treatment of multiple myelomaOriol, Albert et al. | 2020
- 447
-
Cui bono? Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromesShallis, Rory M. / Podoltsev, Nikolai A. / Gowda, Lohith / Zeidan, Amer M. / Gore, Steven D. et al. | 2020
- 461
-
Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agentsGómez-De León, Andrés / Villela-Martínez, Luis Mario / Yáñez-Reyes, José Miguel / Gómez-Almaguer, David et al. | 2020
- 471
-
Risk assessment of venous thromboembolism in hematological cancer patients: a reviewChan, Thomas Sau-Yan / Hwang, Yu Yan / Tse, Eric et al. | 2020
- 481
-
An update on disease biomarkers for Hodgkin lymphomaCirillo, Melita / Borchmann, Sven et al. | 2020
- 489
-
Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefitsShallis, Rory M. / Stahl, Maximilian / Bewersdorf, Jan Philipp / Hendrickson, Jeanne E. / Zeidan, Amer M. et al. | 2020
- 501
-
Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidenceMusto, Pellegrino / La Rocca, Francesco et al. | 2020
- 519
-
Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscapeShapiro, Roman M. / Antin, Joseph H. et al. | 2020
- 533
-
Enhancing CAR T cell efficacy: the next step toward a clinical revolution?Namuduri, Manjusha / Brentjens, Renier J. et al. | 2020
- 545
-
Clinical spectrum, risk factors, management and outcome of patients with retroperitoneal hematoma: a retrospective analysis of 3-year experienceSahu, Kamal Kant / Mishra, Ajay Kumar / Lal, Amos / George, Susan V. / Siddiqui, Ahmad Daniyal et al. | 2020
- 557
-
Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017Durup, Darshana / Schaffalitzky de Muckadell, Philip / Strom, Claes Christian et al. | 2020
- 565
-
Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysisHui, Li / Qi, Li / Guoyu, Hu / Xuliang, Shen / Meiao, Tan et al. | 2020